FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1874232016> ?p ?o ?g. }

• W1874232016 endingPage "86" @default.
• W1874232016 startingPage "579" @default.
• W1874232016 abstract "Calcium is one of the key elements to consider in patients on dialysis due to its relationship with cardiovascular risk. The introduction of non-calcium-based phosphate binders and calcimimetics has changed the setting for pre-dialysis serum calcium in recent years from 9.5-10.5mg/dl to 8.5-9.5mg/dl. To assess more accurately the changes in calcium (Ca) during haemodialysis sessions and to individualise prescriptions, the aim of this study was to assess the intradialytic changes of two different dialysate Ca concentrations before and after hemodialysis and their implications in controlling calcium-phosphate metabolism.We analysed 98 patients with a mean age of 59.3 ± 15 years, 68 of which were men and 30 women. Each patient received two HD sessions with two different dialysate Ca concentrations: 2.5 mEq/l (Ca25 group) or 3.0 mEq/l (Ca30 group). Pre- and post-dialysis Ca, phosphorus (P) and PTH were determined, and associated medications were recorded. For a more individualised analysis, patients were divided into four subgroups of Ca<8.5mg/dl, 8.5-9.0mg/dl, 9.0-9.5mg/dl, and >9.5mg/dl, according to pre-dialysis serum calcium levels.There were no differences in pre-dialysis values of Ca: 8.81 ± 0.65 (CA25) and 8.88 ± 0.61 (CA30), P: 4.01 ± 1.3 (CA25) and 4.19 ± 1.2 (CA30), or PTH: 352 ± 288 (CA25) and 369 ± 310 (CA30). Post-dialysis Ca and PTH did not change significantly with CA25 dialysate, although there was a significant post-dialysis Ca increase to 10.2 ± 0.6 (P<.001) accompanied by a decrease in post-dialysis PTH (181 ± 227, P<.001) with CA30. However, with CA25 dialysate, when different subgroups of pre-dialysis Ca were analysed: <8.5mg/dl (30.6%), 8.5-9.0mg/dl (31.6%), 9.1-9.5mg/dl (23.5%) and >9.5mg/dl (14.3%) we observed a Ca increase during the session in the <8.5 (P<.001) and 8.5-9.0 (P<.01) subgroups. Ca was unchanged in the 9.1-9.5 group and Ca decreased when the initial Ca values were >9.5mg/dL (P<.01). A Ca increase (P<.001) and a decrease in PTH (P<.01) were observed in all subgroups with CA30 dialysate. A total of 42% of patients were taking calcimimetics, 47% paricalcitol, and 32% calcium-based phosphate binders, although these drugs were not linked with pre- or post-dialysis Ca levels in or dialysate treatment.We concluded that the prescription of Ca dialysate needs to be individualised based on pre- and post-dialysis Ca values and the need for an increase, decrease, or no changes in post-dialysis calcium in relation to the clinical condition of the patient's phosphorous-calcium metabolism." @default.
• W1874232016 created "2016-06-24" @default.
• W1874232016 creator A5005436555 @default.
• W1874232016 creator A5013375555 @default.
• W1874232016 creator A5018467661 @default.
• W1874232016 creator A5028710058 @default.
• W1874232016 creator A5032023728 @default.
• W1874232016 creator A5034476004 @default.
• W1874232016 creator A5048277851 @default.
• W1874232016 creator A5050135968 @default.
• W1874232016 creator A5064592202 @default.
• W1874232016 creator A5066058548 @default.
• W1874232016 creator A5067274411 @default.
• W1874232016 creator A5070804401 @default.
• W1874232016 creator A5085795617 @default.
• W1874232016 date "2012-01-01" @default.
• W1874232016 modified "2023-10-11" @default.
• W1874232016 title "Dialysate calcium individualisation: a pending issue." @default.
• W1874232016 cites W1967066959 @default.
• W1874232016 cites W1975664633 @default.
• W1874232016 cites W1978004544 @default.
• W1874232016 cites W1994403324 @default.
• W1874232016 cites W2023370107 @default.
• W1874232016 cites W2030174339 @default.
• W1874232016 cites W2054213958 @default.
• W1874232016 cites W2086094285 @default.
• W1874232016 cites W2105304958 @default.
• W1874232016 cites W2109830428 @default.
• W1874232016 cites W2114548004 @default.
• W1874232016 cites W2115276988 @default.
• W1874232016 cites W2170610314 @default.
• W1874232016 cites W2171118227 @default.
• W1874232016 cites W2181682164 @default.
• W1874232016 cites W2265519523 @default.
• W1874232016 cites W2266257610 @default.
• W1874232016 cites W2415719355 @default.
• W1874232016 cites W2548549197 @default.
• W1874232016 cites W3010153256 @default.
• W1874232016 cites W71307848 @default.
• W1874232016 doi "https://doi.org/10.3265/nefrologia.pre2012.may.11391" @default.
• W1874232016 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23013943" @default.
• W1874232016 hasPublicationYear "2012" @default.
• W1874232016 type Work @default.
• W1874232016 sameAs 1874232016 @default.
• W1874232016 citedByCount "4" @default.
• W1874232016 countsByYear W18742320162015 @default.
• W1874232016 countsByYear W18742320162019 @default.
• W1874232016 countsByYear W18742320162021 @default.
• W1874232016 crossrefType "journal-article" @default.
• W1874232016 hasAuthorship W1874232016A5005436555 @default.
• W1874232016 hasAuthorship W1874232016A5013375555 @default.
• W1874232016 hasAuthorship W1874232016A5018467661 @default.
• W1874232016 hasAuthorship W1874232016A5028710058 @default.
• W1874232016 hasAuthorship W1874232016A5032023728 @default.
• W1874232016 hasAuthorship W1874232016A5034476004 @default.
• W1874232016 hasAuthorship W1874232016A5048277851 @default.
• W1874232016 hasAuthorship W1874232016A5050135968 @default.
• W1874232016 hasAuthorship W1874232016A5064592202 @default.
• W1874232016 hasAuthorship W1874232016A5066058548 @default.
• W1874232016 hasAuthorship W1874232016A5067274411 @default.
• W1874232016 hasAuthorship W1874232016A5070804401 @default.
• W1874232016 hasAuthorship W1874232016A5085795617 @default.
• W1874232016 hasConcept C126322002 @default.
• W1874232016 hasConcept C126894567 @default.
• W1874232016 hasConcept C134018914 @default.
• W1874232016 hasConcept C178790620 @default.
• W1874232016 hasConcept C185592680 @default.
• W1874232016 hasConcept C2778063415 @default.
• W1874232016 hasConcept C2779978075 @default.
• W1874232016 hasConcept C510538283 @default.
• W1874232016 hasConcept C519063684 @default.
• W1874232016 hasConcept C71924100 @default.
• W1874232016 hasConceptScore W1874232016C126322002 @default.
• W1874232016 hasConceptScore W1874232016C126894567 @default.
• W1874232016 hasConceptScore W1874232016C134018914 @default.
• W1874232016 hasConceptScore W1874232016C178790620 @default.
• W1874232016 hasConceptScore W1874232016C185592680 @default.
• W1874232016 hasConceptScore W1874232016C2778063415 @default.
• W1874232016 hasConceptScore W1874232016C2779978075 @default.
• W1874232016 hasConceptScore W1874232016C510538283 @default.
• W1874232016 hasConceptScore W1874232016C519063684 @default.
• W1874232016 hasConceptScore W1874232016C71924100 @default.
• W1874232016 hasIssue "5" @default.
• W1874232016 hasLocation W18742320161 @default.
• W1874232016 hasOpenAccess W1874232016 @default.
• W1874232016 hasPrimaryLocation W18742320161 @default.
• W1874232016 hasRelatedWork W1974087872 @default.
• W1874232016 hasRelatedWork W1974382241 @default.
• W1874232016 hasRelatedWork W1990422519 @default.
• W1874232016 hasRelatedWork W2003842308 @default.
• W1874232016 hasRelatedWork W2012020043 @default.
• W1874232016 hasRelatedWork W2025590009 @default.
• W1874232016 hasRelatedWork W2064236298 @default.
• W1874232016 hasRelatedWork W2095093072 @default.
• W1874232016 hasRelatedWork W2143541377 @default.
• W1874232016 hasRelatedWork W2149561154 @default.
• W1874232016 hasVolume "32" @default.
• W1874232016 isParatext "false" @default.

• next